Inventia Life Science
PrivateLast Round
VC Round
Apr 24, 2025
Total Funding Raised
$37.52M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Inventia Life Science is a biotechnology company that develops and manufactures 3D bioprinting platforms, including printers and bio-inks, to create advanced cell models for biomedical research and drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, 3D Printing, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inventia Life Science Comparables
Compare Inventia Life Science with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VoxCell BioInnovation | 86% | |
| MIMETAS | 83% | |
| Aspect Biosystems | 83% |
Inventia Life Science Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 24, 2025 | ||||
| VC Round | Jan 1, 2023 | ||||
| Series B Extension | Jun 1, 2022 | ||||
| Series B | Dec 15, 2021 | ||||
| Grant | Jul 31, 2020 | ||||
Series A | Nov 27, 2018 |
Key People
Founding team and executive leadership
Inventia Life Science Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Skip Capital | Series B, Series A |
| AirTree | Series A |
| Australian Government | Grant |
| Blackbird Ventures | Series B, Seed, Series A |
| Tenmile | VC Round |
| Main Sequence Ventures | Series A |
| HESTA Industry Super Fund | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 204% MoM.
- Jul 25, 2026
Monthly visitors increased 88% MoM.
Inventia Life Science Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Inventia Life Science's valuation, stock price, and market status.
Is Inventia Life Science a public or private company?
Inventia Life Science is a private company.
What is the current stock price of Inventia Life Science?
Inventia Life Science is a private company, so its shares have no public market price. Caplight tracks Inventia Life Science's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Inventia Life Science worth (valuation)?
Valuation information for Inventia Life Science is not publicly available.
Can I buy Inventia Life Science stock?
Inventia Life Science shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Inventia Life Science's last funding round?
Inventia Life Science's most recent funding round was VC Round on April 24, 2025.
Who are the main investors in Inventia Life Science?
Key investors in Inventia Life Science include Blackbird Ventures.
Will Inventia Life Science IPO soon?
No public IPO plans have been announced for Inventia Life Science.
How can I track Inventia Life Science secondary market activity?
Caplight tracks bids, offers, and trades in Inventia Life Science's shares on secondary markets.